دورية أكاديمية

Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis

التفاصيل البيبلوغرافية
العنوان: Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis
المؤلفون: Hyea Park, Chi Son Chang, Suk-Joo Choi, Soo-young Oh, Cheong-Rae Roh
المصدر: Obstetrics & Gynecology Science, Vol 62, Iss 4, Pp 280-284 (2019)
بيانات النشر: Korean Society of Obstetrics and Gynecology, 2019.
سنة النشر: 2019
المجموعة: LCC:Gynecology and obstetrics
مصطلحات موضوعية: sirolimus, cardiac tumor, rhabdomyoma, tuberous sclerosis, fetal therapy, Gynecology and obstetrics, RG1-991
الوصف: Rhabdomyoma is the most common fetal cardiac tumor, and its development is related to tuberous sclerosis. Fetal cardiac rhabdomyomas often spontaneously regress in utero or after birth, but large tumors can cause hemodynamic obstruction. Sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, has been used as an immunosuppressant after organ transplantation. The mTOR inhibitors are well-known to have anti-tumor activity, and they have been used for the treatment of patients with tuberous sclerosis. In the current case, fetal cardiac rhabdomyoma was completely resolved in utero during oral sirolimus treatment in the mother with tuberous sclerosis. This case shows that oral sirolimus therapy in pregnancy may be a treatment for multiple or large fetal cardiac rhabdomyomas.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Korean
تدمد: 2287-8572
2287-8580
Relation: http://ogscience.org/upload/pdf/ogs-62-280.pdf; https://doaj.org/toc/2287-8572; https://doaj.org/toc/2287-8580
DOI: 10.5468/ogs.2019.62.4.280
URL الوصول: https://doaj.org/article/bc6aa171bb76459a87a41fbda434fa45
رقم الأكسشن: edsdoj.bc6aa171bb76459a87a41fbda434fa45
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:22878572
22878580
DOI:10.5468/ogs.2019.62.4.280